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Abstract 
We determined recent trends and recurrence rates of placenta praevia in 790,366 deliveries in 
NSW. From 2001 to 2009, the rate of placenta praevia increased by 26%, from 0. 69% to 0. 
87% (trend P < 0.001). The placenta praevia recurrence rate in a second birth was 4.8%. 
Two-thirds of the increase in placenta praevia was accounted for by trends in known risk 
factors, and the unexplained portion may reflect changes in unidentified risk factors or in the 
threshold for placenta praevia diagnosis.  
 
Introduction 
Placenta praevia occurs when the placenta is implanted in the lower segment of the uterus, 
presenting ahead of the leading pole of the fetus.1,2 Risk factors for placenta praevia have 
been well documented. Factors associated with increased risk include advancing maternal 
age, multiparity, multiple gestation, previous placenta praevia, caesarean section and 
abortion, infertility treatments, smoking and cocaine use during pregnancy, gestational 
diabetes and male fetuses.3–7 Decreased risk of placenta praevia has been associated with 
gestational hypertension.3,6 Trends in placenta praevia are the result of the effects of changes 
in all these factors and, on balance, are likely to be driving an increase in placenta praevia 
rates. Contemporary estimates of recurrence risk are lacking. The aims of this study were to 
determine recent trends and recurrence rates of placenta praevia in an Australian population. 
 
Materials and Methods 
The study population included 790,366 deliveries (to 525,822 women) during the period 1 
January 2001 to 31 December 2009. Data were obtained from linked NSW population-based 
birth and hospital discharge records. Birth data are from the Perinatal Data Collection, a 
legislated population-based surveillance system covering births _20 weeks’ gestation or 
_400-g birthweight. Hospital discharge data are from the Admitted Patient Data Collection 
(from July 2000), a census of all NSW inpatient hospital discharges (public and private) with 
diagnoses and procedures coded [according to the 10th revision of the International 
Classification of Diseases (ICD10)] for each admission based on information from the 
medical records. The data sets were probabilistically linked and de-identified for analysis 
using methods that have been described previously.8 The study was approved by the NSW 
Population and Health Services Research Ethics Committee.  
 
Placenta praevia was identified by the ICD10 code O44 in the hospital data for women who 
were delivered by caesarean section at or after 26 weeks’ gestation.6 Women who had a 
vaginal birth (n = 881) were not considered to be cases in this study. Placenta praevia 
identification in hospital data has a sensitivity of 88–100%, specificity of 100% and positive 
predictive value of 100% when compared with the medical record.9,10 
 
 
accurately ascertained.11–13 
 
Analysis 
The trend in placenta praevia rates from 2001 to 2009 among all deliveries was assessed 
using the Cochran- Armitage trend test. We used predictive modelling as described 
elsewhere14 to ascertain whether the observed trend could be explained by changes in the 
maternal risk factors over time. If the observed and predicted trends are not significantly 
different, this implies that the available explanatory variables account for all of the increase 
in placenta praevia.14 Conversely, any difference between the observed and predicted trends 
would be because of factors not included in the model. Crude and adjusted odds ratios and 
95% confidence intervals (95% CI) were determined for placenta praevia risk factors only for 
2006 –2009 (so that prior uterine surgery could be included in the logistic regression model.) 
 
The recurrence analyses were limited to women who had a consecutive first and second 
delivery. Women with a first delivery prior to January 2001 or nonconsecutive births (ie 
second birth outside NSW) were excluded. We determined the rate of the first occurrence of 
placenta praevia in first, second or third births and the recurrence rates for women with a 
history of placenta praevia in their first and/or second births using contingency table analysis. 
Singleton and multiple births were examined separately. 
 
Results 
From 1 January 2001 to 31 December 2009, there were 6152 (0.78%) deliveries complicated 
by placenta praevia, with a higher rate among multiple (1.11%) than singleton births (0.78%) 
[relative risk (RR) = 1.42; 95% CI 1.20– 1.69] and among private (1.12%) compared with 
public (0.62%) patients (RR = 1.80; 95% CI 1.72–1.90). The rate of placenta praevia 
increased with parity: first births 0.74%; second births 0.81%; third births 0.80%; fourth 
births 0.88%; fifth and higher parity 1.09%. Maternal risk factors for placenta praevia for the 
period 2006–2009 are presented in Table 1. 
 
From 2001 to 2009, the rate of placenta praevia increased by 26%, from 0.69% to 0.87% 
(trend P < 0.001). The observed and predicted trends are shown in Figure 1 and demonstrate 
that 65% of the increase can be accounted for by the trends in maternal age, smoking, private 
care, previous caesarean, multiple gestation, diabetes, hypertension and assisted reproductive 
technology. 
 
The number of singleton first births over the entire period was 324,227. Of these, 147,468 
(46.6%) also recorded a consecutive singleton birth before the end of the study period, and 
29,693 also had a third consecutive delivery. The women who had a second birth differed 
from those who did not; at their first birth, they were younger (mean age 28.1 years vs 29.1 
years) and less likely to have had a caesarean section (26.5% vs 31.5%) or placenta praevia 
(0.58% vs 0.85%). 
 
For the 856 (0.58%) women with placenta praevia in their first singleton birth, the recurrence 
risk for a second birth with placenta praevia was 4.8% (Fig. 2). Only five of the 41 women 
with a recurrent placenta praevia in their second birth had a third birth in the study period, 
and two had a third placenta praevia. 
 
Among singleton births, the rate of first occurrence of placenta praevia was significantly 
higher following first birth caesarean section compared with vaginal first birth (1.08% vs 
0.58%, RR = 1.87, 1.65–2.12) (Fig. 2). Among the 2,049 women with a multiple birth in their 
second birth, the rate of first occurrence of placenta praevia following vaginal birth was 
0.76% and following caesarean section was 1.49%. 
 
Discussion 
Placenta praevia rates increased by 26% between 2001 and 2009, and two-thirds of the 
increase was explained by increases in established risk factors. For women with a first birth 
placenta praevia, one in 20 will have a recurrence in their second birth. For those having a 
third birth, a second birth without placenta praevia does not appear to mitigate the recurrence 
risk. In second births, the rate of placenta praevia occurrence differed for women with 
multiple gestations and for women with a prior caesarean, and together, the risk was higher 
than either risk factor in isolation. Our restriction to delivery by caesarean section provides a 
conservative estimate of placenta praevia rates, but is consistent with previous research and 
avoids the misclassification of low-lying placenta as placenta praevia.6 
 
The increasing rates of placenta praevia were only partially explained by changes in the 
known risk factors. Although we did not have information on all the established risk factors 
for placenta praevia,3–7 the lack of information on prior uterine surgery or other unidentified 
risk factors is unlikely to entirely explain the difference between the observed and predicted 
trends in placenta praevia. We could not include uterine surgery in the trend model because 
there was no ‘lookback period’ for women at the start of the study period.15 Given the risk 
associated with prior uterine surgery (aOR 1.71 for the period 2006–2009), this could account 
for some of the placenta praevia increase if the proportion of women with a history of prior 
uterine surgery is increasing. 
 
Increased ascertainment is a possible explanation for the unexplained increase in placenta 
praevia. However, this seems unlikely, given the high (88-100%) reported  ascertainment 
rates.9,10 Changes in the method or threshold for diagnosis and/or intervention could also 
account for some of the observed increase in placenta praevia. Transvaginal scans (TVS) are 
more accurate than transabdominal scans (TAS) for placental localisation in second and third 
trimester.1,2,16,17 Thus, widespread use of TVS or Trans Perineal Scanning for confirming 
placental location in the 3rd trimester might be expected to decrease the rate of placenta 
praevia diagnoses, but information on the safety, choice of technique, and timing of such 
assessment in the presence of suspected placenta praevia is lacking. 
 
There have been few population-based studies reporting the recurrence risk of placenta 
praevia.4,5,7 Two older (pre-1993) Scandinavian studies reported recurrence risks for second 
births of 2.3% and 2.4%, respectively.5,7 A recent study from England 2000 to 2009 had a 
recurrence risk of 4.3%, similar to our estimate of 4.8% for the same period.4 The doubling 
of recurrence risk since the 1970s and 1980s likely reflects the changes in diagnostic ability, 
from a period of largely clinical diagnosis in women with painless vaginal bleeding and a 
high presenting part or abnormal lie to current widespread availability of ultrasound and the 
choice of threshold of placental edge-os distance for undertaking a caesarean section.  In 
conclusion, the incidence of placenta praevia has risen faster than can be explained purely by 
known risk factors. Population-based rates of placenta praevia occurrence and recurrence 
provide information for counselling. Women with placenta praevia are at high risk of 
haemorrhage and serious morbidities, including hypovolaemic shock, disseminated 
intravascular coagulopathy, renal failure, liver failure and adult respiratory distress.1,2,6 
Delivery in a hospital with an onsite blood bank and an experienced multidisciplinary team is 
recommended.2,6 
 
Acknowledgements 
We thank the NSW Ministry of Health for access to the population health data and the NSW 
Centre for Health Record Linkage for linking the data sets. This work was supported by a 
National Health and Medical Research Council Project Grant (#512162). CLR is supported 
by a NHMRC Senior Research Fellowship (#457078). 
 
References 
1 Oppenheimer L. Diagnosis and management of placenta previa. J Obstet Gynaecol Can 
2007; 29 (3): 261–273.  
2 Royal College of Obsetricians and Gynecologists. Placenta praevia, placenta praevia 
accreta and vasa praevia: diagnosis and management. Green-top Guideline No 27, 2011. 
[Accessed 20 January 2012.]   3 Faiz AS, Ananth CV. Etiology and risk factors for placenta 
previa: an overview and meta-analysis of observational studies. J Matern Fetal Neonatal Med 
2003; 13(3): 175–190. 4 Gurol-Urganci I, Cromwell DA, Edozien LC et al. Risk of placenta 
previa in second birth after first birth cesarean section: a population-based study and meta-
analysis. BMC Pregnancy Childbirth 2011; 11: 95. 
5 Monica G, Lilja C. Placenta previa, maternal smoking and recurrence risk. Acta Obstet 
Gynecol Scand 1995; 74 (5): 341–345. 
6 Olive EC, Roberts CL, Algert CS, Morris JM. Placenta praevia: maternal morbidity and 
place of birth. Aust N Z J Obstet Gynaecol 2005; 45: 499–504. 
7 Rasmussen S, Albrechtsen S, Dalaker K. Obstetric history and the risk of placenta previa. 
Acta Obstet Gynecol Scand 2000; 79(6): 502–507. 
8 Roberts CL, Ford JB, Algert CS et al. Trends in adverse maternal outcomes during 
childbirth: a population-based study of severe maternal morbidity. BMC Pregnancy 
Childbirth 2009; 9: 7. 
9 Taylor L, Travis S, Pym M et al. How useful are hospital morbidity data for monitoring 
conditions occurring in the perinatal period? Aust N Z J Obstet Gynaecol 2005; 45: 36–41. 
10 Lain SJ, Roberts CL, Hadfield RM et al. Validation of obstetric haemorrhage reporting in 
hospital discharge data. Aust N Z J Obstet Gynaecol 2008; 48: 481–484. 
11 NSW Health Department. Validation study: NSW Midwives Data Collection 1998. New 
South Wales Mothers and Babies 1998: NSW Public Health Bulletin, State Publication no. 
(EPI) 000029, 2000: 9 (S-2): 97–99., 2000. 
12 Bell JC, Ford JB, Cameron CA, Roberts CL. The accuracy of population health data for 
monitoring trends and outcomes among women with diabetes in pregnancy. Diabetes Res 
Clin Pract 2008; 81(1): 105–109. 
13 Roberts CL, Bell JC, Ford JB et al. The accuracy of reporting of the hypertensive 
disorders of pregnancy in population health data. Hypertens Pregnancy 2008; 27 (3): 285–
297.  
14 Ford JB, Roberts CL, Simpson JM et al. Increased postpartum hemorrhage rates in 
Australia. Int J Gynaecol Obstet 2007; 98(3): 237–243. 
15 Chen JS, Roberts CL, Simpson JM, Ford JB. Use of hospitalisation history (lookback) to 
determine prevalence of chronic diseases: impact on modelling of risk factors for 
haemorrhage in pregnancy. BMC Med Res Methodol 2011; 11: 68. 
16 Leerentveld RA, Gilberts EC, Arnold MJ, Wladimiroff JW. Accuracy and safety of 
transvaginal sonographic placental localization. Obstet Gynecol 1990; 76 (5): 759–762. 
17 Sherman SJ, Carlson DE, Platt LD, Medearis AL. Transvaginal ultrasound: does it help in 
the diagnosis of placenta previa? Ultrasound Obstet Gynecol 1992; 2 (4): 256– 260. 
 
